Get the app
US › Healthcare

BeyondSpring Inc (BYSI)

US · Healthcare · Biotechnology

$0.710.00%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-849,000
EPS
$-0.02

Key statistics

Market cap
$25.9M
Forward P/E
10.5
P/B
5.38
Book value
$-0.86
EPS (TTM)
$-0.18
52-week high
$2.44
52-week low
$0.57
50-day MA
$1.06
200-day MA
$1.50
Beta
0.06

Analyst view

Analysts rate BeyondSpring Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $1.25.

Shareholding

Insiders
17.40%
Institutions
14.80%

Largest institutional holders

FundStake
Decheng Capital LLC9.24%
BlackRock Inc1.58%
Vanguard Capital Management, LLC1.48%
Geode Capital Management, LLC0.91%
State Street Corp0.56%
Vanguard Fiduciary Trust Co0.44%
Northern Trust Corp0.17%
Tanaka Capital Management Inc0.06%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for BeyondSpring Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.